Moderna stock rises on positive results in flu vaccine trial

33,058 次觀看・8 個月前

Moderna (MRNA) shares are ticking up this morning after the pharmaceutical company published positive data from its latest flu vaccine trial. Yahoo Finance Health Care Reporter Anjalee Khemlani outlines Moderna's new post-COVID strategy to expand personalized care, quoting CFO James Mock's plans to prepare new COVID, RSV, and flu vaccines this season.